Evidence map›Paper›PMID 39329258›Full record

ArticleChemistryOpen2024

New Tricyclic Aryl Quinazoline Derivatives by Suzuki-Miyaura Cross-Coupling.

Burkhon Elmuradov, Rasul Okmanov, Bakhromjon Juraev, Gerald Dräger, Holger Butenschön

Abstract read
In one paragraph

Article in ChemistryOpen, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Burkhon ElmuradovLeibniz Universität Hannover, Institut für Organische Chemie, Schneiderberg 1B, D-30167, Hannover, Germany.ORCID https://orcid.org/0000-0002-9372-8249
Rasul OkmanovInstitute of the Chemistry of Plant Substances, Academy of Sciences of Uzbekistan, 100170, Mirzo-Ulugbek str. 77, Tashkent, Uzbekistan.ORCID https://orcid.org/0000-0003-2154-0746
Bakhromjon JuraevInstitute of the Chemistry of Plant Substances, Academy of Sciences of Uzbekistan, 100170, Mirzo-Ulugbek str. 77, Tashkent, Uzbekistan.ORCID https://orcid.org/0000-0002-5382-8894
Gerald DrägerLeibniz Universität Hannover, Institut für Organische Chemie, Schneiderberg 1B, D-30167, Hannover, Germany.ORCID https://orcid.org/0000-0003-1988-0469
Holger ButenschönLeibniz Universität Hannover, Institut für Organische Chemie, Schneiderberg 1B, D-30167, Hannover, Germany.ORCID https://orcid.org/0000-0002-7689-1992

Funding

Georg Forster Research Fellowship for Experienced Researchers of the Alexander von Humboldt Foundation 1186936Ministry of Higher Education, Science and Innovations of Uzbekistan F-FA-2021-408Research Fellowship by the German Academic Exchange Service (DAAD)
6 · The paper itself

Abstract

A number of new deoxyvasicinone (2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one) and mackinazolinone (6,7,8,9-tetrahydro-11H-pyrido[2,1-b]quinazolin-11-one) derivatives with aryl substituents at C7/C8 and at C5 are reported. These compounds are rare representatives of their kind and were prepared in high yields by Suzuki-Miyaura cross-coupling reactions between 7-bromo-2,3-dihydro[2,1-b]quinazoline-9-(1H)-one, 5,7-dibromo-2,3-dihydro[2,1-b]quinazoline-9-(1H)-one or 8-bromomackinazolinone and respective arylboronic acids with palladium acetate as the catalyst. The products were characterized spectroscopically and, in addition, by X-ray crystal structure analyses in six cases.

Indexed as

Cross-CouplingPalladium CatalysisQuinazolineSuzuki-Miyaura Reaction

Identifiers

PMID39329258
PMCPMC11625927

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.